Last reviewed · How we verify
conventional therapy plus umbilical cord serum eye drop — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
conventional therapy plus umbilical cord serum eye drop (conventional therapy plus umbilical cord serum eye drop) — Shahid Beheshti University of Medical Sciences.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| conventional therapy plus umbilical cord serum eye drop TARGET | conventional therapy plus umbilical cord serum eye drop | Shahid Beheshti University of Medical Sciences | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- conventional therapy plus umbilical cord serum eye drop CI watch — RSS
- conventional therapy plus umbilical cord serum eye drop CI watch — Atom
- conventional therapy plus umbilical cord serum eye drop CI watch — JSON
- conventional therapy plus umbilical cord serum eye drop alone — RSS
Cite this brief
Drug Landscape (2026). conventional therapy plus umbilical cord serum eye drop — Competitive Intelligence Brief. https://druglandscape.com/ci/conventional-therapy-plus-umbilical-cord-serum-eye-drop. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab